• 

  Alzheimer’s Drug Leqembi Approved in Canada
• 

  Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
• 

  Australia Drug Regulators Approve Leqembi for Alzheimer’s
• 

  France, UK Insurers Say They Won’t Cover Alzheimer’s Drug Leqembi
• 

  FDA Approved: An Injectable Version of Alzheimer’s Drug Leqembi
• 

  4 Big Questions About New Alzheimer’s Anti-Amyloid Drugs, Answered
• 

  How Safe Is Alzheimer’s Drug Leqembi — and Who’s Taking It?
• 

  OP-ED: Why UK Health Insurers Were Right to Reject New Alzheimer’s Drugs
• 

  EU Approves Leqembi: Regulators Flip from ‘No’ to ‘Yes’ on Alzheimer’s Drug
• 

  Australia Is Latest Country to Say ‘No’ to Leqembi
• 

  AHEAD Study Trial Participant Shares His Experience
• 

  ‘Mission Critical’: Why the FDA Approved an Alzheimer’s Drug Update During Comms Freeze
• 

  Leqembi Vs. Kisunla: An Alzheimer’s Drug Point-by-Point Comparison
• 

  A 90-year-old Skier on Living an Active Life With an Alzheimer’s Diagnosis
• 

  One Year In, 5 Things We’ve Learned From Patients on Leqembi

12Next